Mediclinic International Stock

Mediclinic International Net Income 2025

Mediclinic International Net Income

254.92 M GBP

Ticker

MDC.L

ISIN

GB00B8HX8Z88

WKN

A1W0TP

In 2025, Mediclinic International's profit amounted to 254.92 M GBP, a 9.92% increase from the 231.92 M GBP profit recorded in the previous year.

The Mediclinic International Net Income history

YEARNET INCOME (undefined GBP)
2027e311.59
2026e269.22
2025e254.92
2024e231.92
2023e206.38
2022151
202168
2020-320
2019-151
2018-492
2017229
2016177
2015241
201449.3
201339.3
201238.2
201131.7
201024.7

Mediclinic International Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Mediclinic International, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Mediclinic International from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Mediclinic International’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Mediclinic International. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Mediclinic International’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Mediclinic International’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Mediclinic International’s growth potential.

Mediclinic International Revenue, EBIT and net profit per share

DateMediclinic International RevenueMediclinic International EBITMediclinic International Net Income
2027e4.13 B GBP457.1 M GBP311.59 M GBP
2026e3.86 B GBP412.11 M GBP269.22 M GBP
2025e3.83 B GBP400.4 M GBP254.92 M GBP
2024e3.69 B GBP382 M GBP231.92 M GBP
2023e3.58 B GBP357.41 M GBP206.38 M GBP
20223.23 B GBP273 M GBP151 M GBP
20213 B GBP202 M GBP68 M GBP
20203.08 B GBP325 M GBP-320 M GBP
20192.93 B GBP325 M GBP-151 M GBP
20182.88 B GBP354 M GBP-492 M GBP
20172.75 B GBP364 M GBP229 M GBP
20162.11 B GBP289 M GBP177 M GBP
20151.98 B GBP321 M GBP241 M GBP
2014272.8 M GBP51.9 M GBP49.3 M GBP
2013233.5 M GBP48 M GBP39.3 M GBP
2012204.7 M GBP38.9 M GBP38.2 M GBP
2011182.7 M GBP31.4 M GBP31.7 M GBP
2010156.3 M GBP24.5 M GBP24.7 M GBP

Mediclinic International stock margins

The Mediclinic International margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Mediclinic International. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Mediclinic International.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Mediclinic International's sales revenue. A higher gross margin percentage indicates that the Mediclinic International retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Mediclinic International's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Mediclinic International's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Mediclinic International's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Mediclinic International. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Mediclinic International's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Mediclinic International Margin History

Mediclinic International Gross marginMediclinic International Profit marginMediclinic International EBIT marginMediclinic International Profit margin
2027e36.43 %11.08 %7.55 %
2026e36.43 %10.67 %6.97 %
2025e36.43 %10.45 %6.65 %
2024e36.43 %10.35 %6.28 %
2023e36.43 %9.98 %5.76 %
202236.43 %8.44 %4.67 %
202136.43 %6.74 %2.27 %
202036.43 %10.54 %-10.38 %
201937.69 %11.08 %-5.15 %
201838.14 %12.31 %-17.11 %
201738.3 %13.24 %8.33 %
201640.01 %13.72 %8.4 %
201540.11 %16.24 %12.19 %
201442.74 %19.02 %18.07 %
201342.31 %20.56 %16.83 %
201241.82 %19 %18.66 %
201140.18 %17.19 %17.35 %
201040.05 %15.67 %15.8 %

Mediclinic International Aktienanalyse

What does Mediclinic International do?

Mediclinic International PLC is a leading global healthcare provider that treats patients in a variety of medical specialties. The company was founded in South Africa in 1983 and has since grown steadily. Today, it is represented in various countries such as South Africa, the United Kingdom, and the United Arab Emirates. Mediclinic's business model is based on providing its patients with high-quality medical care. The company operates various clinics and facilities that are specifically tailored to the needs of patients. These include general clinics, specialty clinics, and clinics specialized in treating certain diseases or patient groups. Under the Mediclinic International PLC umbrella, there are various divisions that cover different medical services. One important division is Mediclinic Southern Africa, which focuses on providing healthcare services in South Africa. In this segment, the company operates several hospitals, clinics, and medical facilities that all operate at a high level. Another important division is Mediclinic Middle East, which focuses on caring for patients in the United Arab Emirates. The company operates several clinics that specialize in various medical specialties. These include clinics for pediatrics, orthopedics, and neurology, as well as clinics specializing in the treatment of cancer and other serious illnesses. A third important division of Mediclinic is Mediclinic Switzerland, which operates various clinics and medical facilities in Switzerland. Here, the company focuses primarily on providing high-quality medical services in areas such as orthopedics and oncology. In addition to the various divisions, Mediclinic also operates a range of products targeting patients and medical professionals. These include various medical devices used in the diagnosis and treatment of patients. Furthermore, the company also offers a range of medical training and continuing education programs to support and keep medical professionals up to date. Overall, Mediclinic International PLC aims to provide patients in different countries and medical specialties with the best possible care. The company operates a variety of clinics and facilities, each operating at a high level. Additionally, Mediclinic offers a range of products and medical training to support both patients and professionals. Mediclinic International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Mediclinic International's Profit Margins

The profit margins of Mediclinic International represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Mediclinic International's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Mediclinic International's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Mediclinic International's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Mediclinic International’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Mediclinic International stock

How much profit has Mediclinic International made this year?

Mediclinic International has made 254.92 M GBP this year.

How has the profit developed compared to last year?

The profit has increased by 9.92% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Mediclinic International publish its earnings?

Mediclinic International publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Mediclinic International?

The profits of Mediclinic International are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Mediclinic International?

You can learn more about the earnings of Mediclinic International by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Mediclinic International pay?

Over the past 12 months, Mediclinic International paid a dividend of 0.03 GBP . This corresponds to a dividend yield of about 0.6 %. For the coming 12 months, Mediclinic International is expected to pay a dividend of 0.03 GBP.

What is the dividend yield of Mediclinic International?

The current dividend yield of Mediclinic International is 0.6 %.

When does Mediclinic International pay dividends?

Mediclinic International pays a quarterly dividend. This is distributed in the months of January, July, January, September.

How secure is the dividend of Mediclinic International?

Mediclinic International paid dividends every year for the past 6 years.

What is the dividend of Mediclinic International?

For the upcoming 12 months, dividends amounting to 0.03 GBP are expected. This corresponds to a dividend yield of 0.59 %.

In which sector is Mediclinic International located?

Mediclinic International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mediclinic International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mediclinic International from 8/26/2022 amounting to 0.03 GBP, you needed to have the stock in your portfolio before the ex-date on 8/4/2022.

When did Mediclinic International pay the last dividend?

The last dividend was paid out on 8/26/2022.

What was the dividend of Mediclinic International in the year 2024?

In the year 2024, Mediclinic International distributed 0.566 GBP as dividends.

In which currency does Mediclinic International pay out the dividend?

The dividends of Mediclinic International are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Mediclinic International stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Mediclinic International

Our stock analysis for Mediclinic International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediclinic International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.